trastuzumab,lapatinib
medsir,novartis,roche
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'altto', 'medsir']
nice translational work presented by at #esmo22 identify subgroups -using pam50- associated with prognosis in pts receiving adjuvant trastuzumab in the phase iii altto trial. it may help to design de-escalation/escalation approaches. 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM